Back to results
US 2003/0216293 A1Published application
Use of composition comprising at least one substance within the group GnRH-analogues for treatment of obsessive -compulsive disorder (OCD)
OwnerTomas Erikssoninventor
Life of this patent
Estimating the term…
Abstract
The invention relates to the use of a composition comprising at least one substance within the group GnRH-analogues for producing a drug for treatment of obsessive-compulsive disorder (OCD). The invention makes it possible for patients suffering from OCD to obtain partial or total relief of symptoms by treatment with a composition which comprises at least one substance within the group GnRH-analogues.
Claims10
Use of a composition comprising at least one substance within the group GnRH-analogues for producing a drug for treatment of obsessive-compulsive disorder (OCD).
Dependencies are inferred from the claim text.